IL33 and Hepatic fibrosis: Hence, in liver fibrosis, evidence indicate that when acute and massive liver damage occurs, the release of IL-33 might act as an activator of tissue-protective mechanisms, while in cases of chronic injury IL-33 shows a significant liver fibrosis promoting effect in an ST2-, Th2- dependent fashion across the entire spectrum of liver pathology.